Stanley-Laman Group’s Calumet Specialty Products CLMT Stock Holding History

Stanley-Laman Group’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,415	Closed	-$299K	–	268
2016 Q1	$299K	Sell	25,415 -67,873	-73%	-$944K	0.06%	210
2015 Q4	$1.86M	Buy	93,288 +43,235	+86%	+$1.07M	0.32%	99
2015 Q3	$1.22M	Buy	50,053 +284	+0.6%	+$7.38K	0.25%	101
2015 Q2	$1.27M	Buy	49,769 +1,216	+3%	+$32.2K	0.23%	110
2015 Q1	$1.17M	Buy	48,553 +11,432	+31%	+$289K	0.21%	119
2014 Q4	$832K	Sell	37,121 -3,881	-9%	-$101K	0.16%	146
2014 Q3	$1.13M	Sell	41,002 -280	-0.7%	-$8.46K	0.22%	120
2014 Q2	$1.31M	Sell	41,282 -434	-1%	-$12.9K	0.24%	111
2014 Q1	$1.08M	Buy	41,716 +3,060	+8%	+$83.5K	0.19%	141
2013 Q4	$1.01M	Buy	+38,656	New	+$1.08M	0.22%	116

Other funds holding CLMT

Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

SOAMC

Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Stanley-Laman Group's CLMT Position: Q2 2016 in Review

Stanley-Laman Group sold out of Calumet Specialty Products (CLMT) in Q2 2016, closing a stake of 25,415 shares — an estimated $299K sold.

Stanley-Laman Group first reported a position in CLMT in Q4 2013 and held it in 10 quarters. The position peaked at $1.86M in Q4 2015. 90 funds tracked by Wall St. Rank hold CLMT as of Q2 2016.

Stanley-Laman Group reported no remaining Calumet Specialty Products position as of Q2 2016 after selling out during the quarter.
Stanley-Laman Group sold 25,415 Calumet Specialty Products shares in Q2 2016, an estimated $299K.
Stanley-Laman Group first reported a position in Calumet Specialty Products in Q4 2013 and held it in 10 quarters.
Stanley-Laman Group's Calumet Specialty Products position peaked at $1.86M in Q4 2015.
90 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2016.

Based on Stanley-Laman Group's 13F filing for Q2 2016, filed 4 Aug 2016.